John Armitage
Egerton Capital
John Armitage Edwards Lifesciences Corp stake
total: 222
Egerton Capital EW trades
- Total transactions:
- 3
- New positions:
- 1
- Sold out:
- 1
- Reduced:
- 1
- Held since:
- 2017 Q2
- Held for:
- 2 quarters
- Latest activity:
- 2017 Q4
According to 2026 Q2 report, John Armitage doesn't hold any Edwards Lifesciences Corp (EW) shares. To date, the estimated cost basis is nearly $39.41 for "buy" trades and estimated average "sell" price is $36.44. Egerton Capital first purchased EW in 2017 Q2, initially acquiring about 5.53M shares. Since the initial investment in Edwards Lifesciences Corp (EW), Egerton Capital has made 2 more transactions.
When did John Armitage sell Edwards Lifesciences Corp (EW)?
John Armitage sold off the entire Edwards Lifesciences Corp (EW) position in 2017 Q4.
When did John Armitage buy Edwards Lifesciences Corp (EW)?
John Armitage first invested in Edwards Lifesciences Corp (EW) in 2017 Q2 at the reported quarter-end price of $39.41 per share.
What's the cost basis of Egerton Capital's EW stake?
The estimated cost basis for Edwards Lifesciences Corp (EW) stake is around $39.41 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $39.41
- Weighted AVG sell price:
- $36.44
John Armitage's historical trades in Edwards Lifesciences Corp
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.